Novel Pharmacological Treatments

Treatment of osteoporosis is achieved by using SERMS most commonly. Strontium ranelete and hormonal replacement therapy in post-menopausal women shows effective treatment of osteoporosis. Treatment for pain in osteoarthritis is done using acetaminophen primarily. NSAIDS and opioids may also be used for treatment of osteoarthritis and most of the musculoskeletal disorders including rheumatoid arthritis. Disease-modifying antirheumatic drugs can slow the progression of rheumatoid arthritis which includes methotrexate, leflunomide, hydroxychloroquine and sulfasalazine.

  • SERMs
  • Hormone replacement therapy (HRT)
  • NSAIDS
  • Opioids
  • Disease modifying Anti rheumatic Drugs
  • Glucosamine
  • SAMe
  • New drugs in Development

Related Conference of Novel Pharmacological Treatments

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 27-28, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 17-18, 2020

3rd Global Meeting on Diabetes and Endocrinology

Kualalumpur, Malaysia
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Novel Pharmacological Treatments Conference Speakers